| Dr Jeffrey A Rosenblatt, MD | |
|
96 Campus Drive, Suite 1, Scarborough, ME 04074 | |
| (207) 885-9905 | |
| (207) 396-5600 |
| Full Name | Dr Jeffrey A Rosenblatt |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 96 Campus Drive, Scarborough, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285660092 | NPI | - | NPPES |
| 30008992 | Medicaid | NH | |
| 017244 | Other | ANTHEM | |
| 284470099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD13091 (Maine) | Primary |
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
While oral appliances such as splints and bite guards are the most common treatment for facial pain from temporomandibular disorders, patients rate them as less helpful than self-care treatments, such as jaw exercises or warm compresses, finds a new study by researchers at NYU College of Dentistry.
As school districts across the nation revamped curricula to meet requirements of the federal "No Child Left Behind" Act, opportunities for children to be physically active during the school day diminished significantly.
A study published in the Journal of Clinical Lipidology found that higher levels of EPA and DHA omega-3 polyunsaturated fatty acids in red blood cells were associated with a lower risk of all-cause mortality in postmenopausal women.
By comparing 140 sequenced bacterial genomes, researchers have uncovered a system for regulating genes essential to bacterial replication - and they did it solely by computer keystrokes and mouse clicks.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.
› Verified 2 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285738310 PECOS PAC ID: 9335043967 Enrollment ID: O20040525000396 |
News Archive
While oral appliances such as splints and bite guards are the most common treatment for facial pain from temporomandibular disorders, patients rate them as less helpful than self-care treatments, such as jaw exercises or warm compresses, finds a new study by researchers at NYU College of Dentistry.
As school districts across the nation revamped curricula to meet requirements of the federal "No Child Left Behind" Act, opportunities for children to be physically active during the school day diminished significantly.
A study published in the Journal of Clinical Lipidology found that higher levels of EPA and DHA omega-3 polyunsaturated fatty acids in red blood cells were associated with a lower risk of all-cause mortality in postmenopausal women.
By comparing 140 sequenced bacterial genomes, researchers have uncovered a system for regulating genes essential to bacterial replication - and they did it solely by computer keystrokes and mouse clicks.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.
› Verified 2 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
While oral appliances such as splints and bite guards are the most common treatment for facial pain from temporomandibular disorders, patients rate them as less helpful than self-care treatments, such as jaw exercises or warm compresses, finds a new study by researchers at NYU College of Dentistry.
As school districts across the nation revamped curricula to meet requirements of the federal "No Child Left Behind" Act, opportunities for children to be physically active during the school day diminished significantly.
A study published in the Journal of Clinical Lipidology found that higher levels of EPA and DHA omega-3 polyunsaturated fatty acids in red blood cells were associated with a lower risk of all-cause mortality in postmenopausal women.
By comparing 140 sequenced bacterial genomes, researchers have uncovered a system for regulating genes essential to bacterial replication - and they did it solely by computer keystrokes and mouse clicks.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey A Rosenblatt, MD 301c Us Route One, Scarborough, ME 04074 Ph: (207) 396-8600 | Dr Jeffrey A Rosenblatt, MD 96 Campus Drive, Suite 1, Scarborough, ME 04074 Ph: (207) 885-9905 |
News Archive
While oral appliances such as splints and bite guards are the most common treatment for facial pain from temporomandibular disorders, patients rate them as less helpful than self-care treatments, such as jaw exercises or warm compresses, finds a new study by researchers at NYU College of Dentistry.
As school districts across the nation revamped curricula to meet requirements of the federal "No Child Left Behind" Act, opportunities for children to be physically active during the school day diminished significantly.
A study published in the Journal of Clinical Lipidology found that higher levels of EPA and DHA omega-3 polyunsaturated fatty acids in red blood cells were associated with a lower risk of all-cause mortality in postmenopausal women.
By comparing 140 sequenced bacterial genomes, researchers have uncovered a system for regulating genes essential to bacterial replication - and they did it solely by computer keystrokes and mouse clicks.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.
› Verified 2 days ago
Dr. Mary C. Fahrenbach, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Drive, Suite 1, Scarborough, ME 04074 Phone: 207-885-9905 Fax: 207-396-5600 | |
Mark A Wrona, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 51 Us Route 1 Ste I, Scarborough, ME 04074 Phone: 207-303-3300 Fax: 207-250-2139 | |
Dr. Mylan C. Cohen, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 96 Campus Drive, Suite 1, Scarborough, ME 04074 Phone: 207-885-9905 Fax: 207-396-5600 | |
Mirle A Kellett, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Dr, Suite 1, Scarborough, ME 04074 Phone: 207-396-5611 | |
Dr. Warren D Alpern, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Dr, Suite 1, Scarborough, ME 04074 Phone: 207-396-5611 | |
Dr. Eleni Nicole Nackos, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Campus Dr Unit 108, Scarborough, ME 04074 Phone: 207-303-3300 Fax: 207-250-2139 | |
Susan Miesfeldt, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Campus Drive, Suite 110, Scarborough, ME 04074 Phone: 207-396-7678 Fax: 207-396-8766 |